Redhill Biopharma Ltd ADR Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Cash Balance Quarterly4.1MTarget: Sufficient working capital to fund operations beyond 12 months
Net Revenues (Continuing and Discontinued Operations) Annually7.8MTarget: Accelerated market penetration and expanded reach of Talicia
Gross Margin (Continuing and Discontinued Operations) Annually7,460.0%
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: Closing bid price below $1.00 for 30 consecutive business daysAction: Regain compliance by achieving a closing bid price of $1.00 or more for at least 10 consecutive business days before October 5, 2026
- Kukbo Co. Ltd. Judgment EnforcementTrigger: Commencement of recognition and enforcement proceedings in KoreaAction: Pursue collection of the final New York Supreme Court judgment totaling approximately $10.9 million
- Going Concern StatusTrigger: Substantial doubt expressed by management regarding ability to continue as a going concernAction: Realize cash from legal victories, achieve licensing milestones, or raise additional capital to extend runway
Research as of 20 Jun 2026